StonvexLoading…
StonvexStonvexStonvexCore line items from INTA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-10 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $152.73M | $425.27M | $279.24M | $139.03M | $504.12M |
Operating Income | Not available | $-35.88M | $-21.63M | $-14.46M | $-27.36M |
Net Income | Not available | $-35.78M | $-20.29M | $-14.35M | $-18.22M |
EPS (Diluted) | $0.37 | $-0.44 | $-0.25 | $-0.18 | $-0.23 |
Total Assets | Not available | $709.14M | $795.18M | $823.26M | $894.16M |
Total Liabilities | Not available | $388.94M | $384.93M | $336.90M | $374.40M |
Cash & Equivalents | Not available | $146.82M | $191.15M | $273.44M | $313.11M |
Free Cash Flow OCF − CapEx | Not available | $98.81M | $35.45M | $13.24M | $121.86M |
Shares Outstanding | Not available | 76.94M | 80.23M | 81.69M | 81.88M |